Modeling of enzyme–substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10

The matrix metalloproteases (MMPs) and the ADAMs (A Disintegrin And Metalloprotease domain) are proteolytic enzyme families containing a catalytic zinc ion, that are implicated in a variety of normal and pathological processes involving tissue remodeling and cancer. Synthetic MMP inhibitors have been designed for applications in pathological situations. However, a greater understanding of substrate binding and the catalytic mechanism is required so that more effective and selective inhibitors may be developed for both experimental and clinical purposes. By modeling a natural substrate spanning P4-P4′ in complex with the catalytic domains, we aim to compare substrate-specificities between Stromelysin-1 (MMP-3), ADAM-9 and ADAM–10, with the aid of molecular dynamics simulations. Our results show that the substrate retains a favourable antiparallel beta-sheet conformation on the P-side in addition to the well-known orientation of the P′-region of the scissile bond, and that the primary substrate selectivity is dominated by the sidechains in the S1′ pocket and the S2/S3 region. ADAM-9 has a hydrophobic residue as the central determinant in the S1′ pocket, while ADAM-10 has an amphiphilic residue, which suggests a different primary specificity. The S2/S3 pocket is largely hydrophobic in all three enzymes. Inspired by our molecular dynamics calculations and supported by a large body of literature, we propose a novel, hypothetical, catalytic mechanism where the Zn-ion polarizes the oxygens from the catalytic glutamate to form a nucleophile, leading to a tetrahedral oxyanion anhydride transition state.

[1]  G. Weskamp,et al.  MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains , 1996, The Journal of cell biology.

[2]  B. Strooper,et al.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. , 2001, The Journal of biological chemistry.

[3]  First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. , 1993 .

[4]  R. Pickersgill,et al.  Molecular dynamics simulation of a phospholipase A2-substrate complex. , 1993, Biochimica et biophysica acta.

[5]  M. Navre,et al.  Rapid Identification of Highly Active and Selective Substrates for Stromelysin and Matrilysin Using Bacteriophage Peptide Display Libraries (*) , 1995, The Journal of Biological Chemistry.

[6]  A. Cameron,et al.  Energetics of the proposed rate‐determining step of the glyoxalase I reaction , 1999, FEBS letters.

[7]  R. Huber,et al.  Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.

[8]  H. Tsuzuki,et al.  Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors. , 1999, Journal of medicinal chemistry.

[9]  M. Browner,et al.  Matrilysin-inhibitor complexes: common themes among metalloproteases. , 1996, Biochemistry.

[10]  G. Weskamp,et al.  Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity* , 1999, The Journal of Biological Chemistry.

[11]  A M Hassell,et al.  Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. , 1994, Science.

[12]  D. Hupe,et al.  A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition* , 2000, The Journal of Biological Chemistry.

[13]  D. Koshland,et al.  The importance of orientation factors in enzymatic reactions. , 1972, Cold Spring Harbor symposia on quantitative biology.

[14]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[15]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[16]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[17]  P. Slocombe,et al.  TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .

[18]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[19]  W. Bretz,et al.  Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.

[20]  石川 聡,et al.  Matrix Metalloproteinase , 1997, Definitions.

[21]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[22]  Richard Hughey,et al.  Hidden Markov models for detecting remote protein homologies , 1998, Bioinform..

[23]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[24]  大房 健 基礎講座 電気泳動(Electrophoresis) , 2005 .

[25]  M. Saraste,et al.  FEBS Lett , 2000 .

[26]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[27]  H J Berendsen,et al.  Molecular dynamics simulations of N‐terminal peptides from a nucleotide binding protein , 1996, Proteins.

[28]  P. Primakoff,et al.  The ADAM gene family: surface proteins with adhesion and protease activity. , 2000, Trends in genetics : TIG.

[29]  N. Borkakoti,et al.  Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor , 1994, Nature Structural Biology.

[30]  D. Fairlie,et al.  Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity. , 2002, Journal of medicinal chemistry.

[31]  P. Slocombe,et al.  The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.

[32]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[33]  N. Mckie,et al.  The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. , 1998, Biochemical and biophysical research communications.

[34]  M. T. Brewer,et al.  Identification and Characterization of a Pro-tumor Necrosis Factor-α-processing Enzyme from the ADAM Family of Zinc Metalloproteases* , 1997, The Journal of Biological Chemistry.

[35]  D. Moras,et al.  Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. , 2001, Journal of molecular biology.

[36]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[37]  B. Barnett,et al.  Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes. , 1999, Journal of molecular biology.

[38]  M. Eschbach,et al.  Cleavage specificity of type IV collagenase (gelatinase) from human skin. Use of synthetic peptides as model substrates. , 1989, The Journal of biological chemistry.

[39]  R. Zahler Enzyme Structure and Mechanism , 1979, The Yale Journal of Biology and Medicine.

[40]  R. Huber,et al.  Structural implications for the role of the N terminus in the ‘superactivation’ of collagenases , 1994, FEBS letters.

[41]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[42]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.